Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/130298
Systemic inflammation and acute-on-chronic liver failure: too much, not enough
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
ACLF is a specific, but complex and multifactorial form of acute decompensation of cirrhosis and is characterized by an extraordinary dynamic natural course, rapidly evolving organ failure, and high short-term mortality. Dysbalanced immune function is central to its pathogenesis and outcome with an initial excessive systemic inflammatory response that drives organ failure and mortality. Later in its course, immuno-exhaustion/immunoparalysis prevails predisposing the patient to secondary infectious events and reescalation in end-organ dysfunction and mortality. The management of patients with ACLF is still poorly defined. However, as its pathophysiology is gradually being unravelled, potential therapeutic targets emerge that warrant further study such as restoring or substituting albumin via plasma exchange or via albumin dialysis and evaluating usefulness of TLR4 antagonists, modulators of gut dysbiosis (pre- or probiotics), and FXR-agonists.
Matèries
Matèries (anglès)
Citació
Citació
LALEMAN, Wim, CLÀRIA I ENRICH, Joan, MERWE, Schalk van der, MOREAU, Richard, TREBICKA, Jonel. Systemic inflammation and acute-on-chronic liver failure: too much, not enough. _Canadian Journal Of Gastroenterology And Hepatology_. 2018. Vol. 2018, núm. 1027152. [consulta: 25 de febrer de 2026]. ISSN: 2291-2797. [Disponible a: https://hdl.handle.net/2445/130298]